Moleculin Engages Industry Veteran Adriano Treve to Explore Accelerated Strategic Partnerships

Stock Information for Qutoutiao Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Qutoutiao Inc.

Moleculin Accelerates Recruitment in Phase 3 Acute Myeloid Leukemia "MIRACLE" Clinical Trial
Moleculin Doses First EU Patient in Phase 3 Pivotal MIRACLE Trial for Treatment of Acute Myeloid Leukemia
Moleculin Announces Exercise of Warrants for $6.0 Million Gross Proceeds
Moleculin Issues New Positive AML Overall Survival Data:
Moleculin to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
Moleculin Reports Second Quarter 2025 Financial Results and Highlights
Moleculin Biotech, Inc. Unveils Promising Preclinical Data of Annamycin in Liver Cancer Treatment
Moleculin Participates in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.